The Burnet Diagnostics Initiative (BDI) is the culmination of Burnet’s broad-based expertise in addressing the most pressing global health challenges through life sciences and implementation research. We provide a sustainable model for diagnostic development with proven results.
This flyer contains information about our pipeline of diagnostics work, tests available for licensing, and our partners.
This flyer contains information about our rapid point of care (POC) test for measuring alanine transaminase (ALT) levels, test applications, and our partners.